Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative with Evident Efficacy in Patients with Muscle Invasive Bladder Cancer
A phase II study of gemcitabine plus cisplatin chemotherapy in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterious DNA damage response DDR gene alterations
A Prospective, Non-Interventional Study to Assess the Prevalence of PD-L1
Expression in the First-Line Setting of Locally Advanced/Unresectable or
Metastatic Urothelial Carcinoma
A Phase I/II Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC Patients who are BCG Na�ve or Received Incomplete BCG Treatment LEGEND STUDY